Fanny Cavalie - 14 Feb 2022 Form 3/A - Amendment Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role: Chief Strategy/Bus Ops Officer
Signature: /s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol: FHTX
Transactions as of: 14 Feb 2022
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 09 Sep 2022, 19:38:11 UTC
Date Of Original Report: 24 Feb 2022
Next filing: 30 Jan 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	FHTX	Stock Options (Right to buy)	14 Feb 2022	Common Stock	125,000	$14.87	Direct	F1
holding	FHTX	Stock Options (Right to buy)	14 Feb 2022	Common Stock	50,000	$16.63	Direct	F2
holding	FHTX	Stock Options (Right to buy)	14 Feb 2022	Common Stock	59,459	$8.77	Direct	F3
holding	FHTX	Stock Options (Right to buy)	14 Feb 2022	Common Stock	10,135	$3.72	Direct	F4
holding	FHTX	Stock Options (Right to buy)	14 Feb 2022	Common Stock	5,575	$0.7300	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests as to 25% of the underlying shares of common stock on January 26, 2023, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F2	The option vests as to 25% of the underlying shares of common stock on January 28, 2022, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F3	The option vests as to 25% of the underlying shares of common stock on August 17, 2021, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F4	The option vests as to 25% of the underlying shares of common stock on January 30, 2020, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F5	The option vests as to 25% of the underlying shares of common stock on March 19, 2019, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.

Remarks:

Due to an administrative error, the vesting schedule of each of the awards set forth in Table II was incorrectly described in the original Form 3 filed on February 24, 2022. This Form 3/A includes the corrected vesting schedule for each such award. This Form 3/A is also being filed to include the Reporting Person's Power of Attorney as Exhibit 24.